LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 78 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $116,721 | -47.2% | 49,458 | +64.2% | 0.00% | 0.0% |
| Q3 2022 | $221,000 | -10.2% | 30,116 | -38.3% | 0.00% | -50.0% |
| Q1 2022 | $246,000 | -80.8% | 48,802 | -70.6% | 0.00% | -83.3% |
| Q4 2021 | $1,284,000 | +113.3% | 165,884 | +308.0% | 0.01% | +50.0% |
| Q3 2021 | $602,000 | +540.4% | 40,658 | +600.2% | 0.01% | +700.0% |
| Q2 2021 | $94,000 | – | 5,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $47,583,104 | 33.50% |
| Orland Properties Ltd | 15,093,969 | $35,621,767 | 18.69% |
| Foresite Capital Management IV, LLC | 10,000,000 | $23,600,000 | 12.24% |
| MIC Capital Management UK LLP | 3,060,569 | $7,222,943 | 1.38% |
| Alphabet Inc. | 5,865,125 | $13,841,695 | 0.77% |
| HSG Holding Ltd | 3,045,997 | $7,188,553 | 0.76% |
| XTX Topco Ltd | 286,614 | $676,409 | 0.14% |
| Eagle Health Investments LP | 100,000 | $236,000 | 0.05% |
| BBR PARTNERS, LLC | 164,041 | $387,137 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 90,172 | $212,806 | 0.04% |